Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, explains current knowledge on the pathology of atopic dermatitis and use of targeted ...
Please provide your email address to receive an email when new articles are posted on . The tests can identify disease subsets as well as the molecular pathways driving disease. Not only can the tests ...
SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease remission in autoimmune diseases, with a Phase 1b trial in atopic dermatitis patients expected to begin in Q1 2026 ...
Atopic dermatitis (AD) is a chronic inflammatory skin disorder associated with increased oxidative stress. In this context, pharmacological activation of the Keap1-Nrf2 pathway, a key regulator of ...
'1104 reduces key indices of skin inflammation and inflammatory mediators in a chronic allergen-driven model of atopic dermatitis (AD) GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Sept. 18, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results